sorafenib tosylate
SpainDrugs containing this active substance
-
It is used to treat liver cancer, advanced-stage kidney cancer (when standard treatment is ineffective or unsuitable), and thyroid cancer.
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 200 mg Manufacturer: Bayer Ag
-
It is used to treat liver cancer and also advanced-stage kidney cancer when other treatments have not worked or are not suitable.
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used to treat liver cancer, advanced-stage kidney cancer (when standard treatment is ineffective or unsuitable), and thyroid cancer.
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat liver cancer (hepatocellular carcinoma) and advanced kidney cancer when other treatments have not worked or are not suitable.
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 548 mg Manufacturer: Laboratorio Stada S.L.
-
It is used to treat liver cancer (hepatocellular carcinoma), thyroid cancer, and advanced-stage kidney cancer when other treatments have not worked or are not suitable.
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg Manufacturer: Teva Pharma S.L.U.
-
It is used to treat liver cancer (hepatocellular carcinoma), advanced-stage kidney cancer (when standard treatment has not worked or is not suitable), and thyroid cancer (differentiated thyroid carcinoma).
Form: tablets, film-coated
Active substance Dosage sorafenib tosylate 274 mg Manufacturer: Viatris Limited